 <h1>Beclomethasone Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to beclomethasone: inhalation aerosol liquid</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, beclomethasone may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking beclomethasone:</p><p>
<i>More common</i>
</p><ul>
<li>Body aches or pain</li>
<li>congestion</li>
<li>cough</li>
<li>difficulty with breathing</li>
<li>dryness or soreness of the throat</li>
<li>fever</li>
<li>hoarseness</li>
<li>runny nose</li>
<li>tender, swollen glands in the neck</li>
<li>trouble swallowing</li>
<li>voice changes</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Attack, assault, or force</li>
<li>blindness</li>
<li>blurred vision</li>
<li>changes in behavior</li>
<li>chills</li>
<li>darkening of the skin</li>
<li>decreased vision</li>
<li>diarrhea</li>
<li>dizziness</li>
<li>eye pain</li>
<li>fainting</li>
<li>headache</li>
<li>loss of appetite</li>
<li>lower back or side pain</li>
<li>mental depression</li>
<li>nausea</li>
<li>painful or difficult urination</li>
<li>skin rash</li>
<li>sore mouth or tongue</li>
<li>tearing</li>
<li>thoughts of killing oneself</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
<li>white patches in the mouth or on the tongue</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of beclomethasone may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Cramps</li>
<li>heavy bleeding</li>
<li>pain</li>
<li>pain or tenderness around the eyes and cheekbones</li>
<li>stuffy or runny nose</li>
<li>tightness of the chest</li>
</ul><p>
<!-- end inhalation aerosol liquid --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to beclomethasone: compounding powder, inhalation aerosol, inhalation aerosol with adapter</i></p><h3>General</h3><p>The most commonly reported adverse reactions have included headache, pharyngitis, rhinitis, inhalation site and taste sensation.<sup>[Ref]</sup></p><h3>Endocrine</h3><p>Oral therapy: </p>
<p>Following 4 weeks of oral therapy for ulcerative colitis, a reduction of plasma cortisol levels has been observed in up to 25% of patients; HPA-axis function recovery is expected to be transient, however follow up data is lacking.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Dysmenorrhea</p>
<p><b>Uncommon</b> (0.1% to 1%): Menorrhagia</p>
<p><b>Very rare</b> (less than 0.01%): Adrenal suppression, Cushing syndrome, cushingoid features<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Pharyngitis (up to 27%)</p>
<p><b>Common</b> (1% to 10%): Rhinitis, hoarseness, throat irritation, upper respiratory tract infection, dysphonia</p>
<p><b>Uncommon</b> (0.1% to 1%): Bronchitis, coughing, epistaxis</p>
<p><b>Rare</b> (0.01% to 0.1%): Acute asthma episode, hemoptysis, respiratory disorder, sinusitis</p>
<p><b>Very rare</b> (less than 0.01%): Paradoxical bronchospasm with wheezing</p>
<p><b>Frequency not reported</b>: Eosinophilic pneumonia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Oral candidiasis of mouth and throat </p>
<p><b>Uncommon</b> (0.1% to 1%): Abdominal pain, constipation</p>
<p><b>Rare</b> (0.01% to 0.1%): Dyspepsia, unspecified gastrointestinal disorders, nausea, tongue discoloration, toothache<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity reactions including rashes, urticaria, pruritus, erythema</p>
<p><b>Very rare</b> (less than 0.01%): Hypersensitivity reactions including edema of the eyes, face, lips, and throat (angioedema), anaphylaxis and anaphylactoid reactions<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Glaucoma, cataracts</p>
<p><b>Postmarketing reports</b>: Blurred vision, central serous chorioretinopathy<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Anxiety</p>
<p><b>Rare</b> (0.01% to 0.1%): Depression, insomnia, sleep disorders, hyperactivity, aggression, irritability (mostly in children)</p>
<p><b>Postmarketing reports</b>: Suicidal ideation<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 25%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Dizziness, dysphonia, migraine </p>
<p><b>Rare</b> (0.01% to 0.1%): Neuropathy, tremor, vertigo<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Rash, purpura</p>
<p><b>Rare</b> (0.01% to 0.1%): Photosensitivity reaction, skin disorder, urticaria</p>
<p><b>Frequency not reported</b>: Easy bruising, skin thinning<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Myalgia, muscle cramps, back pain</p>
<p><b>Very rare</b> (less than 0.01%): Growth retardation, decrease in bone mineral density<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Chest pain, edema</p>
<p><b>Rare</b> (0.01% to 0.1%): Hypertension, palpitations, angina pectoris<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Inhalation site sensation and taste sensation<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Increased weight<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Qvar (beclomethasone)." Teva Pharmaceuticals USA, North Wales, PA. </p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about beclomethasone</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>173 Reviews</li>
<li>Drug class: inhaled corticosteroids</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Beclomethasone Inhalation &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Qvar, Qvar RediHaler, Beclovent</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Asthma, Maintenance</li>
<li>Reversible Airways Disease, Maintenance</li>
<li>Bronchitis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to beclomethasone: compounding powder, inhalation aerosol, inhalation aerosol with adapter</i></p><h3>General</h3><p>The most commonly reported adverse reactions have included headache, pharyngitis, rhinitis, inhalation site and taste sensation.<sup>[Ref]</sup></p><h3>Endocrine</h3><p>Oral therapy: </p><p>Following 4 weeks of oral therapy for ulcerative colitis, a reduction of plasma cortisol levels has been observed in up to 25% of patients; HPA-axis function recovery is expected to be transient, however follow up data is lacking.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Dysmenorrhea</p><p><b>Uncommon</b> (0.1% to 1%): Menorrhagia</p><p><b>Very rare</b> (less than 0.01%): Adrenal suppression, Cushing syndrome, cushingoid features<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Pharyngitis (up to 27%)</p><p><b>Common</b> (1% to 10%): Rhinitis, hoarseness, throat irritation, upper respiratory tract infection, dysphonia</p><p><b>Uncommon</b> (0.1% to 1%): Bronchitis, coughing, epistaxis</p><p><b>Rare</b> (0.01% to 0.1%): Acute asthma episode, hemoptysis, respiratory disorder, sinusitis</p><p><b>Very rare</b> (less than 0.01%): Paradoxical bronchospasm with wheezing</p><p><b>Frequency not reported</b>: Eosinophilic pneumonia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Oral candidiasis of mouth and throat </p><p><b>Uncommon</b> (0.1% to 1%): Abdominal pain, constipation</p><p><b>Rare</b> (0.01% to 0.1%): Dyspepsia, unspecified gastrointestinal disorders, nausea, tongue discoloration, toothache<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity reactions including rashes, urticaria, pruritus, erythema</p><p><b>Very rare</b> (less than 0.01%): Hypersensitivity reactions including edema of the eyes, face, lips, and throat (angioedema), anaphylaxis and anaphylactoid reactions<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Glaucoma, cataracts</p><p><b>Postmarketing reports</b>: Blurred vision, central serous chorioretinopathy<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Anxiety</p><p><b>Rare</b> (0.01% to 0.1%): Depression, insomnia, sleep disorders, hyperactivity, aggression, irritability (mostly in children)</p><p><b>Postmarketing reports</b>: Suicidal ideation<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 25%)</p><p><b>Uncommon</b> (0.1% to 1%): Dizziness, dysphonia, migraine </p><p><b>Rare</b> (0.01% to 0.1%): Neuropathy, tremor, vertigo<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Rash, purpura</p><p><b>Rare</b> (0.01% to 0.1%): Photosensitivity reaction, skin disorder, urticaria</p><p><b>Frequency not reported</b>: Easy bruising, skin thinning<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Myalgia, muscle cramps, back pain</p><p><b>Very rare</b> (less than 0.01%): Growth retardation, decrease in bone mineral density<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Chest pain, edema</p><p><b>Rare</b> (0.01% to 0.1%): Hypertension, palpitations, angina pectoris<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Inhalation site sensation and taste sensation<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Increased weight<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Qvar (beclomethasone)." Teva Pharmaceuticals USA, North Wales, PA. </p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about beclomethasone</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>173 Reviews</li>
<li>Drug class: inhaled corticosteroids</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Beclomethasone Inhalation &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Asthma, Maintenance</li>
<li>Reversible Airways Disease, Maintenance</li>
<li>Bronchitis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>